Crown Bioscience

Developer of drugs for cancer and CVMD (Cardiovascular and Metabolic Diseases)

placeSanta Clara, California, United States calendar_todayFounded 2006 groups18 employees language crownbio.com

Registered entities

Social engagement

Social engagement: 39.4K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

18 investors on record; lead investors include Orbimed, Qiming Venture Partners, The CID Group, Argonaut Private Equity; 1 has since exited.

Investor typeCountShare
Venture capital1372%
Private equity211%
Angel & family office16%
Other / undisclosed211%

Hiring activity

Hires periodically

3 roles tracked across 3 of the last 12 months

10 Mar 2026 · Study Director/Scientist, Preclinical In Vivo Oncology · Kannapolis

12 Jan 2026 · Quality Assurance Specialist · San Diego

11 Oct 2025 · Research Associate · Kannapolis

5 Aug 2025 · Manufacturing Assistant · Durham

Based on job postings tracked across public sources.

Recent activity

30 Jun 2026
Expansion
North Carolina
24 Jun 2026
Partnership
Crown Bioscience
24 Jun 2026
Expansion
North Carolina
Coming soon